Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
9.78
+0.62 (6.77%)
Nov 2, 2026, 1:25 PM CST
SHA:603108 Revenue
Shanghai Runda Medical Technology had revenue of 1.60B CNY in the quarter ending September 30, 2026, a decrease of -11.13%. This brings the company's total for the last twelve months to 6.52B, down -11.92% year-over-year. In the year 2025, Shanghai Runda Medical Technology had annual revenue of 7.00B, down -15.80%. That makes Shanghai Runda Medical Technology the 7,725th largest company in the world by revenue and 1,140th in China.
Revenue (ttm)
6.52B
Revenue Growth
-11.92%
P/S Ratio
0.85
Revenue / Employee
2.21M
Employees
2,945
Market Cap
5.91B
Revenue by Segment
- Commerce (Distribution Services) 6.53B 93.4%
- Industry (Own Brand) 458.21M 6.6%
Fiscal year ended Dec 31, 2025 See the full SHA:603108 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.00B | -1.31B | -15.80% |
| Dec 31, 2024 | 8.31B | -835.59M | -9.13% |
| Dec 31, 2023 | 9.15B | -1.35B | -12.84% |
| Dec 31, 2022 | 10.49B | 1.63B | 18.45% |
| Dec 31, 2021 | 8.86B | 1.79B | 25.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 9.94B |
| Maccura Biotechnology Co.Ltd | 2.18B |
| Medicalsystem Biotechnology | 1.68B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Amoy Diagnostics | 1.20B |
| Berry Genomics Co.,Ltd | 920.76M |
| SMO ClinPlus CO.,LTD. | 819.71M |